Expression and Characterization of Canine Cytochrome P450 2D15
- 1 September 1998
- journal article
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 357 (1) , 27-36
- https://doi.org/10.1006/abbi.1998.0801
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Impact of P450 genetic polymorphism on the first-pass extraction of cardiovascular and neuroactive drugsAdvanced Drug Delivery Reviews, 1997
- Nomenclature for human CYP2D6 allelesPharmacogenetics, 1996
- Human Drug-Metabolizing Enzyme Polymorphisms: Effects on Risk of Toxicity and CancerDNA and Cell Biology, 1996
- P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclaturePharmacogenetics, 1996
- The role of cytochrome P450 enzymes in hepatic and extrahepatic human drug toxicityPharmacology & Therapeutics, 1995
- Genetic analysis of the CYP2D locus in relation to debrisoquine hydroxylation capacity in Korean, Japanese and Chinese subjectsPharmacogenetics, 1995
- Is environmental carcinogenesis modulated by host polymorphism?Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1991
- Identification of the primary gene defect at the cytochrome P450 CYP2D locusNature, 1990
- Mechanisms of cytochrome P‐450 catalysisThe FASEB Journal, 1990
- The molecular mechanisms of two common polymorphisms of drug oxidation-evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidationXenobiotica, 1986